Celltrion launches Remsima SC in UK

Mar 2, 2020

On 02 March 2020, Celltrion launched Remsima SC, its subcutaneous infliximab product, in the UK. To support the launch, Celltrion held a symposium at which it showcased the product and supporting data. Celltrion has signed a framework agreement with the NHS to supply the product.

Print Page Mail Article